Navigation Links
Global Biologic Drugs Market to Jump to Over $220 Billion by 2019 says Latest Report
Date:11/21/2013

DUBLIN, Ireland, November 21, 2013 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/q6n3x8/biologics_and) has announced the addition of the "Biologics and Biosimilars World Markets" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769)

Biologics, also known as biopharmaceuticals, can be categorized into three main modalities: therapeutic proteins, monoclonal antibodies and vaccines. Most of the biologic drugs marketed so far are recombinant therapeutic protein drugs, which are used to relieve patients suffering from chronic diseases, such as cancer, diabetes, cardiovascular diseases, infertility and cystic fibrosis. Globally, the U.S. commands 43% of biologics sales, followed by the E.U. (21%) and Japan (9%).

The "Expanding Markets for Biologics and Biosimilars" report covers key biologic and biosimilar drugs, including:

  • Humira (Adalimumab)
  • Remicade (Infliximab)
  • Lantus (Insulin Glargine)
  • Levemir (Insulin Detemir)
  • Privigen (Immune Globulin Intravenous)
  • Perjeta (Pertuzumab)
  • Soliris (Eculizumab)
  • Eylea (Aflibercept)
  • Revlimid (Lenalidomide)
  • Herceptin (Trastuzumab)
  • Gardasil
  • Varivax (Varicella Virus Vaccine Live)
  • Gammagard Liquid (Immune Globulin Infusion (Human))
  • Aranesp (Darbepoetin Alfa)
  • Enbrel (Etanercept)
  • Epogen/Procrit/Eprex/Erypo (Epoetin Alfa)
  • Genotropin (Somatropin)
  • Herceptin (Trastuzumab)
  • Humira (Adalimumab)
  • Neulasta (Pegfilgrastim)
  • Neupogen (Filgrastim)
  • Remicade (Infliximab)
  • Rituxan/MabThera (Rituximab)

The "Expanding Markets for Biologics and Biosimilars" report examines companies manufacturing biologic and biosimilar equipment and supplies in the world.

Companies covered include:

- AbbVie, Inc
- Abbott Laboratories
- Actelion Ltd
- Amgen, Inc
- Amoytop Biotech Co, Ltd
- Anhui Anke Biotechnology (Group) Co, Ltd
- Apotex, Inc
- Astellas Pharma, Inc
- AstraZeneca
- Bayer AG
- Beijing Four Rings Biopharmaceuticals
- Bharat Serums and Vaccines Limited
- Bio, Inc
- Biocon Ltd
- Biogen Idec, Inc
- Bioton SA
- Boehringer Ingelheim Pharmaceuticals, Inc
- Bristol-Myers Squibb, Co
- Celgene Corporation
- Celltrion, Inc
- Cipla Ltd
- Dr Reddy's Laboratories Ltd
- Elan Corporation, PLC
- Eli Lilly & Co
- Gideon Richter
- Gilead Sciences, Inc
- GlaxoSmithKline PLC
- Hospira, Inc
- Intas Pharmaceuticals Limited
- Johnson & Johnson
- Merck & Co, Inc
- Mylan, Inc
- Novartis AG
- Pfizer, Inc
- Roche Holdings AG
- Sandoz International GmbH
- Sanofi
- Stada Arzneimittel Aktiengesellschaft
- Teva Pharmaceutical Industries Limited
- Watson Pharmaceuticals, Inc 

Detailed charts with sales forecasts and marketshare data are included.

For more information visit http://www.researchandmarkets.com/research/q6n3x8/biologics_and

About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: +1-646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals



'/>"/>
SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. High Temperature Plastics - Making Conventional Material Obsolete - Global Strategic Business Report 2013
2. Neurology Devices Market (CSF Shunts, CSF Drainage, Clot Retriever, Snare, Embolic Coil, Flow Diversion, Neurosurgery & Neurostimulation Devices) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
3. Global Medical Antimicrobial Coatings Market 2012-2016
4. Ophthalmic Instrumentation - Global Strategic Business Report - 2012 Featuring Abbott, Bausch & Lomb, Carl Zeiss and Others
5. Laboratory Glassware And Plasticware - 2012 Global Strategic Business Report Profiles 91 Companies Including Many Key and Niche Players
6. Blood Processing Supplies and Equipment - Global Strategic Business Report
7. Intravenous Equipment - Global Strategic Business Report
8. Global Medical Laser Systems Market Report 2013-2018: Global Aesthetics Laser Market Poised to Grow
9. Global Coagulation Self-Testing Devices, Markets, Players and Prospects Report 2013
10. Global Point-of-Delivery Drug Reconstitution Systems Market Report 2013 - 2017
11. Noser Engineering AG Expand Medical Device Technology Offering Meeting the Needs of Global Regulatory Compliance and Accelerating Time to Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... 27, 2017   Royal Philips (NYSE: ... leader in health technology, today announced 510(k) clearance ... to market its ElastQ Imaging capability, further expanding ... systems. ElastQ Imaging enables simultaneous imaging of tissue ... for the diagnosis of various liver conditions. With ...
(Date:2/27/2017)... , Feb. 27, 2017  RegeneRx Biopharmaceuticals, Inc. ... drug development company focused on tissue protection, repair ... RGN-137, GtreeBNT Co., Ltd., received a positive response ... clinical trial design for RGN-137 to treat epidermolysis ... gel that incorporates Thymosin beta 4 ("Tß4") as ...
(Date:2/27/2017)... BioPharma Corp. (CTI BioPharma) (NASDAQ and MTA: CTIC) today announced ... President and Chief Executive Officer (CEO) and member of the ... Richard Love , interim President and CEO who will ... Craig has over 20 years of experience in hematology, oncology ... Europe . "On behalf of CTI BioPharma,s ...
Breaking Medicine Technology:
(Date:2/27/2017)... ... 2017 , ... Miro is the ultimate smart media center that offers a ... TV shows and much more apps for user exploration. Its innovative acoustic design with ... 1280 x 720 provides crisp images with remarkable clarity and color. The WiFi connection ...
(Date:2/27/2017)... ... 27, 2017 , ... Sunshine Coast Health Centre (SCHC), one ... at https://www.sunshinecoasthealthcentre.ca/ , is proud to announce the addition of a registered ... Centre's commitment to innovation in drug rehab and alcohol treatment strategies beyond a ...
(Date:2/27/2017)... (PRWEB) , ... February 27, 2017 , ... New Jersey ... rates, among all types and genders. And the need for advanced services is growing. ... and its top-rated cancer care program, in collaboration with their non-profit partners in their ...
(Date:2/26/2017)... ... February 26, 2017 , ... This is ... the world’s first to be ISO/IEC 17025:2005 INAB accredited for Der p 1 ... 17025:2005 is the globally recognised standard that sets out requirements for the technical ...
(Date:2/26/2017)... ... 2017 , ... IndustryArchive.Org . is announcing a new way for B2B ... now only pay for B.A.N.T. quality sales leads based on the Sellers decision to ... new reality that B2B buyers are controlling the sales process via the Internet and ...
Breaking Medicine News(10 mins):